Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: A case report

Journal of Investigative Dermatology

Volumn 118, Issue 4, 2002, Pages 595-599

  Pedersen, Lars Østergaard ^a   Vetter, Claudia S ^b   Mingari, Maria C ^c   Andersen, Mads Hald ^a   Thor Straten, Per ^a   Bröcker, Eva B ^b   Becker, Jürgen C ^a,b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmunity; Cellular; Hypopigmentation; Immunity; Self tolerance

Indexed keywords

CD94 ANTIGEN; DIFFERENTIATION ANTIGEN; HLA ANTIGEN; RECEPTOR SUBTYPE; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPIGMENTATION; IMMUNOHISTOCHEMISTRY; LEUKODERMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITILIGO;

EID: 0036229032     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01698.x     Document Type: Article

References (29)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Accumulation of identical T cells in melanoma and vitiligo-like leukoderma
3. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
4. Early signaling via inhibitory and activating NK receptors
5. Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method
6. The enigma of activating isoforms of ITIM-bearing molecules
7. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors
8. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
9. Tumor-specific immune response: Current in vitro analyses may not reflect the in vivo immune status
10. Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals
11. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
12. NK cell receptors
13. On guard- Activating NK cell receptors
14. Signal transduction during natural killer cell activation. Inside the mind of a killer
15. Regulation of immune responses through inhibitory receptors
16. Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: A regulated mechanism that controls T-cell activation and function
17. Stimulatory receptors in NK and T cells
18. Vitiligo in patients with metastatic melanoma: A good prognostic sign
19. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
20. Efficient assembly of recombinant major histocompatibility molecules with preformed disulfide bonds
21. Inhibitory receptors sensing HLA-G1 molecules in pregnancy. Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor
22. Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy
23. Harnessing self-reactivity in cancer immunotherapy
24. Why tyrosinase for treatment of melanoma
25. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
26. Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture
27. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma
28. T cells expressing killer cell inhibitory receptors do not carry TCR for alloantigens
29. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo